Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian C Monk

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Science (New York, N.Y.)|July 19, 2008
Outwitting multidrug resistance to antifungalsBrian C Monk, Andre Goffeau
Journal of Fungi (Basel, Switzerland)|January 27, 2021
Roles for Structural Biology in the Discovery of Drugs and Agrochemicals Targeting Sterol 14α-DemethylasesBrian C Monk, Mikhail V Keniya
Journal of Fungi (Basel, Switzerland)|December 24, 2021
Correction: Monk, B.C.; Keniya, M.V. Roles for Structural Biology in the Discovery of Drugs and Agrochemicals Targeting Sterol 14α-Demethylases. <i>J. Fungi</i> 2021, <i>7</i>, 67Brian C Monk, Mikhail V Keniya
Current Drug Targets. Infectious Disorders|February 7, 2003
Genomic pathways to antifungal discoveryBrian C Monk, Richard D Cannon
FEMS Yeast Research|July 11, 2019
Attenuated apoptotic BAX expression as a xenobiotic reporter in Saccharomyces cerevisiaeMikhail V Keniya, Brian C Monk
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 1, 2005
Peptide motifs for cell-surface intervention: application to anti-infective and biopharmaceutical developmentBrian C Monk, David R K Harding
Journal of Fungi (Basel, Switzerland)|December 30, 2020
Sterol 14α-Demethylase Ligand-Binding Pocket-Mediated Acquired and Intrinsic Azole Resistance in Fungal PathogensKatharina Rosam, Brian C Monk, Michaela Lackner
Journal of Fungi (Basel, Switzerland)|December 22, 2022
Exploring <i>Cryptococcus neoformans</i> CYP51 and Its Cognate Reductase as a Drug TargetYasmeen N Ruma, Mikhail V Keniya, Brian C Monk
Journal of Fungi (Basel, Switzerland)|February 25, 2023
Functional Expression of Recombinant <i>Candida auris</i> Proteins in <i>Saccharomyces cerevisiae</i> Enables Azole Susceptibility Evaluation and Drug DiscoveryStephanie Toepfer, Michaela Lackner, Mikhail V Keniya, et al.
Journal of Fungi (Basel, Switzerland)|October 25, 2024
Azole Combinations and Multi-Targeting Drugs That Synergistically Inhibit <i>Candidozyma auris</i>Stephanie Toepfer, Mikhail V Keniya, Michaela Lackner, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Science (New York, N.Y.)|July 19, 2008
Outwitting multidrug resistance to antifungalsBrian C Monk, Andre Goffeau
Journal of Fungi (Basel, Switzerland)|January 27, 2021
Roles for Structural Biology in the Discovery of Drugs and Agrochemicals Targeting Sterol 14α-DemethylasesBrian C Monk, Mikhail V Keniya
Journal of Fungi (Basel, Switzerland)|December 24, 2021
Correction: Monk, B.C.; Keniya, M.V. Roles for Structural Biology in the Discovery of Drugs and Agrochemicals Targeting Sterol 14α-Demethylases. <i>J. Fungi</i> 2021, <i>7</i>, 67Brian C Monk, Mikhail V Keniya
Current Drug Targets. Infectious Disorders|February 7, 2003
Genomic pathways to antifungal discoveryBrian C Monk, Richard D Cannon
FEMS Yeast Research|July 11, 2019
Attenuated apoptotic BAX expression as a xenobiotic reporter in Saccharomyces cerevisiaeMikhail V Keniya, Brian C Monk
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 1, 2005
Peptide motifs for cell-surface intervention: application to anti-infective and biopharmaceutical developmentBrian C Monk, David R K Harding
Journal of Fungi (Basel, Switzerland)|December 30, 2020
Sterol 14α-Demethylase Ligand-Binding Pocket-Mediated Acquired and Intrinsic Azole Resistance in Fungal PathogensKatharina Rosam, Brian C Monk, Michaela Lackner
Journal of Fungi (Basel, Switzerland)|December 22, 2022
Exploring <i>Cryptococcus neoformans</i> CYP51 and Its Cognate Reductase as a Drug TargetYasmeen N Ruma, Mikhail V Keniya, Brian C Monk
Journal of Fungi (Basel, Switzerland)|February 25, 2023
Functional Expression of Recombinant <i>Candida auris</i> Proteins in <i>Saccharomyces cerevisiae</i> Enables Azole Susceptibility Evaluation and Drug DiscoveryStephanie Toepfer, Michaela Lackner, Mikhail V Keniya, et al.
Journal of Fungi (Basel, Switzerland)|October 25, 2024
Azole Combinations and Multi-Targeting Drugs That Synergistically Inhibit <i>Candidozyma auris</i>Stephanie Toepfer, Mikhail V Keniya, Michaela Lackner, et al.
Pageof 7